The Federal Government on Wednesday confirmed that Nigeria has received the HIV prevention injection, Lenacapavir.
Dr Adebobola Bashorun, the national coordinator of the National HIV, Viral Hepatitis, and STDs Control Programme (NASCP) at the Federal Ministry of Health and Social Welfare, said the arrival of LEN shows Nigeria’s ongoing commitment to using innovative, evidence-based methods to fast-track control of the HIV epidemic.
Bashorun stated, “NASCP, in collaboration with partners and stakeholders, will work to ensure the safe introduction, strategic deployment, and effective integration of Lenacapavir into the national HIV prevention options.
“The rollout will support ongoing efforts to increase access to prevention services while reinforcing Nigeria’s broader HIV response.
“NASCP remains committed to advancing equitable access to HIV prevention, testing, treatment, and care services. The arrival of Long-Acting Injectable Lenacapavir is a clear demonstration of Nigeria’s resolve to scale up innovative solutions and strengthen the fight against HIV. Together, Nigeria moves closer to ending HIV as a public health threat.”
Lenacapavir is an injectable treatment given twice a year, offering an easier alternative to daily oral preventive medicines.
The statement highlighted that introducing Lenacapavir for PrEP is a major step in expanding prevention choices for people at risk of HIV.
“As a long-acting injectable option, LEN PrEP has the potential to improve adherence and expand access to effective HIV prevention services for populations that may face challenges with daily oral prevention options.
“By expanding prevention options and strengthening service delivery, the country is taking decisive steps to reduce new HIV infections and improve health outcomes for communities across Nigeria,” the statement added.
The drug is expected to be available in Nigeria and 119 other low- and middle-income countries at $40 per person per year, under voluntary licensing agreements with generic manufacturers.
“This milestone, approved by the Coordinating Minister of Health and Social Welfare, Prof Ali Pate and supported through the Global Fund, represents a major advancement in the country’s HIV prevention efforts and further strengthens Nigeria’s commitment to expanding innovative HIV prevention options,” the statement concluded.
